Lukas John
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Chemokine receptors and signaling
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 16
- Oncology 7
- Chemokine receptors and signaling 3
- CAR-T cell therapy research 2
- Co-authors
- Niels Weinhold (12 shared papers)Marc S. Raab (12 shared papers)Maria Theresa Krauth (1 shared paper)Hartmut Goldschmidt (10 shared papers)Alexandra M. Poos (7 shared papers)Klaus Podar (1 shared paper)Marc‐Steffen Raab (2 shared papers)Carsten Müller‐Tidow (9 shared papers)
- Journals
- Blood (4 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Cochrane Database of Systematic Reviews (1 paper)Hematological Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Lukas John
18 papers receiving 234 citations
Peers
Comparison fields: 5 of 42
- Hematology 132
- Oncology 78
- Immunology 49
- Health Informatics 3
- Cancer Research 24
Countries citing papers authored by Lukas John
This map shows the geographic impact of Lukas John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas John more than expected).
Fields of papers citing papers by Lukas John
This network shows the impact of papers produced by Lukas John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas John. The network helps show where Lukas John may publish in the future.
Co-authors
The 25 scholars most cited alongside Lukas John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 87 | |
| 2 | 2022 | 39 | |
| 3 | 2021 | 28 | |
| 4 | 2023 | 23 | |
| 5 | Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials. | 1997 | 15 |
| 6 | 2024 | 9 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2021 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Lukas John
Lukas John is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 239 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (16 papers), Chemokine receptors and signaling (3 papers), Cancer Genomics and Diagnostics (2 papers), Protein Degradation and Inhibitors (2 papers), CAR-T cell therapy research (2 papers), Nanowire Synthesis and Applications (1 paper), Advanced Radiotherapy Techniques (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Hematology (132 citations), Oncology (78 citations), Immunology (49 citations), Health Informatics (3 citations) and Cancer Research (24 citations). Lukas John has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Niels Weinhold, Marc S. Raab, Maria Theresa Krauth, Hartmut Goldschmidt, Alexandra M. Poos, Klaus Podar, Marc‐Steffen Raab, Carsten Müller‐Tidow, Anja Baumann and Katharina Bauer. Their work appears in journals such as Blood, European Journal of Nuclear Medicine and Molecular Imaging, Cochrane Database of Systematic Reviews, Hematological Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.